Objective: To evaluate a non-invasive surrogate imaging marker for blood evacuation in patients with IVH. Clinical Relevance: Extension of intracerebral hemorrhage (ICH) to the ventricles increases the 48 hours mortality by 43%, requiring external ventricular drains (EVD) to mitigate hydrocephalus and monitor intracranial pressures. Blood increases CSF viscosity, altering the diffusion coefficient. We hypothesize change in lateral ventricle (LV) DTI metrics, fractional anisotropy (FA) and mean diffusivity (MD), can be used as a marker for blood removal after IVH. Methods: A sub-cohort of 20 patients in SHRINC trial with ICH and IVH were serially imaged at day 1 (T1=20), 14 (T1=20), 28 (T3=16), and 42 (T4=13) on a 3T MRI system. The serial T1w, segmented LV (JHU WM atlas) volumes, FA, and MD maps were registered. The FA and MD of ipsi and contralesional LV were recorded. Clinical assessment (NIHSS) was associated with the change in FA and MD of LV. A mixed model statistical analysis was performed. Results: We serially imaged 11M/9F with average age 55.4±8.7 years. The baseline hematoma volume and NIHSS were 22.1±18.5 cc and 16.1±8.7 respectively. The patients had basal ganglia (n=12) and thalamic (n=8) ICH extended into LV. The ipsilesional FA was significantly (T1=0.24, T4=0.15, p<0.001) decreased (1.17% /day), and MD was significantly (T1 = 1.49*10 -3 mm 2 /sec, T4 = 2.37 *10 -3 mm 2 /sec, p<0.001) increased (2.4 x 10 -5 mm 2 /sec/day). At T4, there was no relationship (p=0.919) between ipsilesional and contra-MD of LV (Fig-1). Patients with higher baseline NIHSS had a significant temporal decline in FA than those with lower NIHSS (p<0.05). Temporally, ipsilesional MD was negatively associated with the baseline NIHSS (p=0.039). Conclusion: The data suggest that DTI metrics of FA and MD are associated with blood clearance from the ipsilesional ventricle.
Background and Objective: Right to left shunts (RLS) found with patent foramen ovale (PFO) are implicated in the pathogenesis of cryptogenic stroke and a risk factor for neurological event. The capability and sensitivity of Transcranial Doppler ultrasound (TCD) to detect a PFO has been established. However, predictors of false positive shunts detected by TCD and benefit of intracardiac echocardiogram (ICE) when studies show conflicting results have not been determined. Methods: In this retrospective study, patients who underwent shunt testing with ICE ± endovascular atrial septal defect closure from 2018 till 2022 were included. We abstracted data regarding the type of study used for shunt detection such as transthoracic echocardiogram (TTE), transesophageal echocardiogram (TEE), ICE and TCD. PFO size and characteristics were evaluated. International consensus criteria were used for TCD PFO detection. Results: A total of 184 patients underwent ICE testing, of which 169 (93.4%) had prior TTE, 116 (63%) TEE, and 48 (25%) prior TCD. Among 48 patients with TCD, 24 had negative TTE and 4 had negative TEE. Mean (SD) age was 51.1(14.4). 110(59.8%) were female. Among all patient with ICE 169 (91.8%) had PFO. PFOs were detected in 38 out of 48 (79.1%) patients who had been assessed with both ICE and TCD, whereas 6 patients (12/5%) were found to have a RLS on TCD but no PFO on ICE, p<0.01. Comparing ICE and TCD grading scores for shunt detected, 45.2% had higher grade by TCD compared to ICE, p= 0.17. Among the six false positive cases on TCD, four of them had shower of microembolization and 2 of them had 0-10 HITS microemboli detection. Conclusion: Transcranial Doppler ultrasound detection of right to left shunt remains highly sensitive and a non-invasive tool. Considering ICE as gold standard, TCD is associated with false positive shunt detection. Further studies are warranted to assess the shunt characteristics on TCD that are associated with higher predictive value for identifying PFO.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.